Cargando…

Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation

Myxoinflammatory fibroblastic sarcoma is a rare malignant soft tissue neoplasm that typically arises on the distal extremities of adults. It usually behaves in a low-grade manner and its characteristic histology is of a lobulated proliferation of moderately atypical spindled to epithelioid cells, va...

Descripción completa

Detalles Bibliográficos
Autores principales: Hallin, Magnus, Miki, Yurina, Hayes, Andrew J, Jones, Robin L, Fisher, Cyril, Thway, Khin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024276/
https://www.ncbi.nlm.nih.gov/pubmed/29977483
http://dx.doi.org/10.1177/2036361318782626
_version_ 1783336027403845632
author Hallin, Magnus
Miki, Yurina
Hayes, Andrew J
Jones, Robin L
Fisher, Cyril
Thway, Khin
author_facet Hallin, Magnus
Miki, Yurina
Hayes, Andrew J
Jones, Robin L
Fisher, Cyril
Thway, Khin
author_sort Hallin, Magnus
collection PubMed
description Myxoinflammatory fibroblastic sarcoma is a rare malignant soft tissue neoplasm that typically arises on the distal extremities of adults. It usually behaves in a low-grade manner and its characteristic histology is of a lobulated proliferation of moderately atypical spindled to epithelioid cells, vacuolated cells, and enlarged or bizarre cells with prominent nucleoli, dispersed within myxoid stroma containing a mixed inflammatory cell infiltrate. The etiology of myxoinflammatory fibroblastic sarcoma remains unknown with no definite causal factors identified. We describe a case of myxoinflammatory fibroblastic sarcoma arising in the foot of a 77-year-old female, which rapidly recurred locally after initial excision and which arose 10 years after renal transplantation. The neoplasm also showed intermingled areas of hemosiderotic fibrolipomatous tumor. The patient also had multifocal areas of squamous cell carcinoma in situ of the foot and hand, in keeping with the clinical context of immune deficiency. This is the second case of myxoinflammatory fibroblastic sarcoma reported to occur after transplantation, but additionally shows hybrid features of hemosiderotic fibrolipomatous tumor, highlights immunocompromise/immunosuppressive therapy as a possible etiologic factor in their development, and adds to the growing number of myxoinflammatory fibroblastic sarcoma that has demonstrated aggressive behavior.
format Online
Article
Text
id pubmed-6024276
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-60242762018-07-05 Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation Hallin, Magnus Miki, Yurina Hayes, Andrew J Jones, Robin L Fisher, Cyril Thway, Khin Rare Tumors Case Report Myxoinflammatory fibroblastic sarcoma is a rare malignant soft tissue neoplasm that typically arises on the distal extremities of adults. It usually behaves in a low-grade manner and its characteristic histology is of a lobulated proliferation of moderately atypical spindled to epithelioid cells, vacuolated cells, and enlarged or bizarre cells with prominent nucleoli, dispersed within myxoid stroma containing a mixed inflammatory cell infiltrate. The etiology of myxoinflammatory fibroblastic sarcoma remains unknown with no definite causal factors identified. We describe a case of myxoinflammatory fibroblastic sarcoma arising in the foot of a 77-year-old female, which rapidly recurred locally after initial excision and which arose 10 years after renal transplantation. The neoplasm also showed intermingled areas of hemosiderotic fibrolipomatous tumor. The patient also had multifocal areas of squamous cell carcinoma in situ of the foot and hand, in keeping with the clinical context of immune deficiency. This is the second case of myxoinflammatory fibroblastic sarcoma reported to occur after transplantation, but additionally shows hybrid features of hemosiderotic fibrolipomatous tumor, highlights immunocompromise/immunosuppressive therapy as a possible etiologic factor in their development, and adds to the growing number of myxoinflammatory fibroblastic sarcoma that has demonstrated aggressive behavior. SAGE Publications 2018-06-20 /pmc/articles/PMC6024276/ /pubmed/29977483 http://dx.doi.org/10.1177/2036361318782626 Text en © The Author(s) 2018 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Hallin, Magnus
Miki, Yurina
Hayes, Andrew J
Jones, Robin L
Fisher, Cyril
Thway, Khin
Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation
title Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation
title_full Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation
title_fullStr Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation
title_full_unstemmed Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation
title_short Acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation
title_sort acral myxoinflammatory fibroblastic sarcoma with hybrid features of hemosiderotic fibrolipomatous tumor occurring 10 years after renal transplantation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024276/
https://www.ncbi.nlm.nih.gov/pubmed/29977483
http://dx.doi.org/10.1177/2036361318782626
work_keys_str_mv AT hallinmagnus acralmyxoinflammatoryfibroblasticsarcomawithhybridfeaturesofhemosideroticfibrolipomatoustumoroccurring10yearsafterrenaltransplantation
AT mikiyurina acralmyxoinflammatoryfibroblasticsarcomawithhybridfeaturesofhemosideroticfibrolipomatoustumoroccurring10yearsafterrenaltransplantation
AT hayesandrewj acralmyxoinflammatoryfibroblasticsarcomawithhybridfeaturesofhemosideroticfibrolipomatoustumoroccurring10yearsafterrenaltransplantation
AT jonesrobinl acralmyxoinflammatoryfibroblasticsarcomawithhybridfeaturesofhemosideroticfibrolipomatoustumoroccurring10yearsafterrenaltransplantation
AT fishercyril acralmyxoinflammatoryfibroblasticsarcomawithhybridfeaturesofhemosideroticfibrolipomatoustumoroccurring10yearsafterrenaltransplantation
AT thwaykhin acralmyxoinflammatoryfibroblasticsarcomawithhybridfeaturesofhemosideroticfibrolipomatoustumoroccurring10yearsafterrenaltransplantation